BioAsia 2013, Conference Agenda

January 28-30, 2013 | HICC, Hyderabad

BioAsia 2013 – Conference Agenda January 28, 2013 09:00-16:00 Hrs Workshops and BioPark Visit (Separate Registrations) 17:00-18:00 Hrs Inaugural Ceremony 18:00-19:00 Hrs Keynote Address Trends in Global BioPharma R&D – Dr. Freda Lewis-Hall, Chief Medical Officer – Worldwide, Pfizer, USA 19:00-20:30 Hrs Welcome Reception January 29, 2013 09:30-10:15 Hrs Keynote Lecture – Dr. Bahija Jallal, Executive Vice President, Research & Development, MedImmune, USA* 10:15-11:45 Hrs Biologics and Biosimilars: Succeeding in the market of the future  Current state of the Biologics and Biosimilars market, including mAbs.  Weighing Needs and Costs  Are the next Block buster’s coming from Biologics Panelists:  Dr. Subir Basak, President (Global Discovery), Jubilant Lifesciences  Dr. Rajesh Ullanat, AVP & Head of Global Tech Development – Biologics, Mylan Pharmaceuticals*  Mr. Melt Van Der Spuy, Chairman & Managing Director, Eli Lilly & Company (India) Pvt. Ltd*  Dr. Himanshu Gadgill, Head – R&D, Intas Biopharmaceuticals Ltd.  Mr. Sachin Joshi, GM Bioprocess, GE Healthcare Pvt. Ltd.  Moderator - Mr. Jasmin Patel, Venture Partner, Aarin Capital 11:45-12:15 Hrs 12:15-13:45 Hrs

Speed Networking (Coffee / Tea Break) Biomedical Research and Regulatory Environment  Fostering Biomedical Research in India  Recent Biosimilar guidelines of Government of India  US FDA's recent Guidance and it's impact Lead Speaker: Mr. Solomon Yimam, Asst. Country Director(Clinical Research), US FDA India Panelists:  Mr. Satish Reddy, Managing Director & COO, Dr. Reddy’s Laboratories, India*  Mr. Ravi Penmetsa, Managing Director, Gland Pharma  Dr AKS Bhujanga Rao, President (R&D and Technical), Natco Pharma*  Moderator – Mr. Vikas Dandekar, India Bureau Chief, Elsevier Business Intelligence

13:45-15:00 Hrs

Lunch and Visit to the exhibition

January 28-30, 2013 | HICC, Hyderabad 15:00-16:30 Hrs

Role of Emerging Markets in global biologics arena: Would India dominate 'Biosimilars'?  Challenges to Biologics and Biosimilars research especially in Asia  Is India ready to take a lead in Biosimilars /bio-better like it did in small molecules generics /branded generics?

Lead Speaker: Dr. Salomon Azoulay, SVP Medical & Development Emerging Markets, Pfizer Panelists:  Mr. Baoping Wang, Head, Novo Nordisk, China  Dr. Alex Kudrin, Medical Assessor, Biological Licensing Division, MHRA, UK  Mr. KV Subramaniam, President & CEO, Reliance Lifesciences  Moderator - Mr. Mike Ward, Editor-in-Chief, Scrip Intelligence, UK

16:30-18:00 Hrs

Increasing Partnerships between Biologics Innovators and Biosimilars manufacturers  Commonalities and differences between global cos and local firms  Bridging the innovation gap  Case studies Lead Speaker: Dr. Shyam Bishen, Head, Emerging Markets Strategy & Commercial Development, Merck & Co. Panelists:  Dr. Abhijit Barve, President – R&D, Biocon Ltd.*  Mr. C Bhaktavatsala Rao, Managing Director, Hospira Healthcare  Mr. C.L. Rathi, Managing Director, Advanced Enzymes  Moderator – Mr. Mahadevan Narayanamoni, Partner - Corporate Finance, Healthcare & Life Sciences Leader, Grant Thornton

18:30-21:00 Hrs CEO Conclave (Only by Invitation) January 30, 2013 09:30-10:15 Hrs Keynote Lecture – Dr. Sridaran Natesan, Vice President- External Innovation (R&D), Science Strategy & Policy, Sanofi 10:15-11:45 Hrs

Is Biologics and Biosimilars a not-to-miss opportunity? – Overall perspective.

Panelists:  Dr. Ajit Shetty, VP Worldwide Operations, Johnson & Johnson & Chairman, Board of Directors, Janssen Pharmaceutica, Belgium  Dr. Rustom Mody, Sr. Vice President – Head R&D, Biotechnology Division - Lupin Ltd.  Dr. Charu Manaktala, Medical Director, Quintiles India  Mr. Anand Iyer, Head of Biotech Division, Strides Arcolabs Ltd.  Moderator - Mr. Aluri Srinivas Rao, Head – PE, Morgan Stanley PE

January 28-30, 2013 | HICC, Hyderabad 11:45-12:15 Hrs 12:15-13:45 Hrs

Speed Networking (Coffee / Tea Break) Next Big Trends in Healthcare  Regenerative Medicine & Stem Cells Chair: Dr. Vishwa Mohan Katoch, Secretary to Government of India, Department of Health Research, Ministry of Health & Family Welfare & Director General, Indian Council of Medial Research* Panelists:  Dr. D. Balasubramainam, Director Research, L. V. Prasad Eye Institute  Shri Sreeshan Raghavan, Joint Secretary, Department of Biotechnology, Govt. of India*  Dr. Mohan C. Vemuri, Director – Stem Cells, Life Technologies*  Dr. Dave Smith, Head, Cell Therapy, Lonza  Canadian FDA Representative*

13:45-15:00 Hrs 15:00-16:30 Hrs

Lunch & Visit to Exhibitions Fostering Industry – Academia Linkages in Bio-Medical R&D  Missing Links and opportunities  Creating IP Ecosystem Lead Speaker: Dr. W. Selvamurthy, Distinguished Scientist & Chief Controller R&D, DRDO Panelists:  Prof. Lam Kong Peng, Director, Bio-Processing Technology Institute, A-Star, Singapore  Mr. Vinod Kuberkar, Managing Director, VTK Lifesciences Advisory Services / Western Range Biopharmaceuticals Pvt. Ltd.  Dr. Taslimarif Saiyed, Director and COO, Centre for Cellular and Molecular Platforms, NCBS-TIFR, Bangalore

16:30 – 17:00 Hrs Regulators’ Meet 17:00 Hrs Valedictory Ceremony & Close *Confirmations awaited